(Q37544504)

20 August 2017

Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections (English)

1 reference

Stenotrophomonas maltophilia

20 August 2017

1 reference

Yu Lin Wang

1

1 reference

20 August 2017

Marco R Scipione

series ordinal

2

1 reference

20 August 2017

Yanina Dubrovskaya

series ordinal

3

1 reference

20 August 2017

John Papadopoulos

series ordinal

4

1 reference

20 August 2017

language of work or name

English

0 references

publication date

21 October 2013

1 reference

20 August 2017

7

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

20 August 2017

58

1 reference

20 August 2017

1

1 reference

20 August 2017

176-182

1 reference

Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Stenotrophomonas maltophilia: an emerging opportunist human pathogen

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Independent predictors for mortality in patients with positive Stenotrophomonas maltophilia cultures

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Antimicrobial therapy for Stenotrophomonas maltophilia infections

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Clinical and microbiologic outcomes in trauma patients treated for Stenotrophomonas maltophilia ventilator-associated pneumonia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Successful treatment of Stenotrophomonas maltophilia soft tissue infection with tigecycline: a case report.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Hospital tap water as a source of stenotrophomonas maltophilia infection

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Impact of initial antimicrobial therapy in patients with bloodstream infections caused by Stenotrophomonas maltophilia

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3910778

Levofloxacin in vitro activity and time-kill evaluation of Stenotrophomonas maltophilia clinical isolates

1 September 2018

1 reference

12 December 2020

Risk factors for epidemic Xanthomonas maltophilia infection/colonization in intensive care unit patients

1 reference

12 December 2020

Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes

1 reference

12 December 2020

Activity of trimethoprim/sulfamethoxazole plus polymyxin B against multiresistant Stenotrophomonas maltophilia

1 reference

12 December 2020

Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia

1 reference

12 December 2020

Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilia

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.01324-13

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

24145530

1 reference